Tirzepatide 5mg  Vendor from China  whatsApp/signal/telegram +86-19831061835 

What is Tirzepatide?

Tirzepatide is a peptide with the ability to assist with glycemic control. Eli Lilly and Company applied for its first patent in early 2016 with its approval occurring later that same year. It is primarily sold as a type of type 2 diabetes medication. However, it has also found a home as a treatment for weight loss for obese and overweight patients. In early 2018, Eli Lilly and Company announced these findings after the completion of the SURPASS-2 trials.

Tirzepatide Molecular Structure

Tirzepatide is an analog of the GIP hormone. The largest difference is that it has a C20 fatty di-acid attached to it. This di-acid is used as a way to optimize the uptake and metabolism of tirzepatide. The overall construction of tirzepatide allows for a longer half life which would mean the extension of down time between necessary doses.